Virbac launches a share buyback program
Following the decision of the board of directors on June 19, 2023 and its approval by the shareholders meeting, we…
359,500€
2,13%
Echtzeit-Aktienkurs VIRBAC SA EO 1,25
Bid:
Ask:
Nachrichten zur VIRBAC SA EO 1,25 Aktie
VIRBAC - 2023 half-year results: publication postponed to end of September
At the end of August, with our priority systems fully restored and functional following the June cyberattack, we will be…
Virbac : Revenue up about 2% during the second quarter and stable at the end of June despite two unfavorable one-off effects throughout the semester
1provisional unaudited revenue that may be adjusted due to the temporary downtime of some of our information systems following the…
Repeat: Virbac reassesses its 2023 growth and Adjusted EBIT1 forecasts
Um den gesamten Artikel unter globenewswire.com zu lesen, klicken Sie bitte auf die Überschrift...…
Virbac Shares Fall on Lower 2023 Forecasts
Virbac Shares Fall on Lower 2023 Forecasts...…
Virbac reassesses its 2023 growth and Adjusted EBIT1 forecasts
Um den gesamten Artikel unter globenewswire.com zu lesen, klicken Sie bitte auf die Überschrift...…
VIRBAC: Slight decline in first-quarter revenue primarily due to a base effect as well as a context of market slowdown
1 Growth at constant exchange rates and scope corresponds to organic growth of sales, excluding exchange rate variations, by calculating…
Virbac : Declaration of the number of shares and voting rights 03/2023
...…
Virbac : Public release of the Year-End Consolidated Accounts at 31 December 2022
Public release of the Year-End Consolidated Accounts at 31 December 2022....…
VIRBAC: 2022 current operating income on the rise at +8.3%, reflecting the momentum of our business over the year in a slowing market
1 Change at constant exchange rates and scope corresponds to the organic growth of sales, excluding exchange rate variations, by…
Virbac : Declaration of the number of shares and voting rights 02/2023
...…
Virbac : Declaration of the number of shares and voting rights 01/2023
...…
Companion Animal Veterinary Vaccines Global Market Report 2023
NEW YORK, Feb. 16, 2023 /PRNewswire/ -- Major players in the companion animal veterinary vaccines market are Boehringer Ingelheim, Eli…
VIRBAC: Annual revenue growth of +9.6% at comparable exchange rates and scope (+14.3% at real rates), driven by exceptional business activity in the fourth quarter
1 Growth at constant exchange rates and scope corresponds to organic growth of sales, excluding exchange rate variations, by calculating…
Virbac : Declaration of the number of shares and voting rights 12/2022
...…
VIRBAC : 2023 Outlook
As we continue to execute our 2030 strategic plan, we have made the decision to continue to accelerate in 2023…
Virbac : Declaration of the number of shares and voting rights 11/2022
...…
Virbac : Declaration of the number of shares and voting rights 10/2022
...…
Virbac : Declaration of the number of shares and voting rights 09/2022
...…
VIRBAC: Revenue growth at end of September at +7.7% at comparable exchange rates and perimeter (+12.7% at actual rates
1 Growth at constant exchange rates and scope corresponds to organic growth of sales, excluding exchange rate variations, by calculating…